Cognizin’s Cognitive Health Benefits to be Highlighted During SLC SupplySide Science Tour April 12

NEW YORK CITY (April 4, 2011) – Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, will present scientific data on Kyowa Hakko’s branded brain health ingredient Cognizin(R) at the SupplySide Science Tour held April 12, 2011, in Salt Lake City, UT. She will highlight results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

Participants were give both the Stroop task, which is designed to measure attention and reaction time, and the Morris Water Maze task, which examines spatial memory while simultaneously undergoing functional Magnetic Resonance Imaging (fMRI). Subjects were then given a daily oral dose of either 500 or 2000 mg of Cognizin for six weeks before a second imaging protocol was conducted. After taking Cognizin, patients showed improved accuracy in generating correct responses, better spatial memory retrieval and increased brain metabolism. 

Results were nearly identical for individuals receiving 500 mg and

2000 mg of Cognizin, confirming that statistically significant improvements in attention, focus, memory and recall can be achieved at dosing levels of 500 mg.

Cognizin Citicoline is a natural, water-soluble brain health ingredient, and is a well-established part of the cognitive health category. Vast research indicates this safe and effective branded compound helps protect neural tissue from free radical damage. It also supports brain performance by enhancing metabolism and healthy activity. Unlike other single-action ingredients for brain health, Cognizin is multi-functional. It has shown to benefit individuals affected by memory loss, mood/behavioral disorders, mild cognitive impairment and certain vision disorders. Cognizin is also highly stable, ultra-pure, allergen-free and has self-affirmed GRAS status, allowing for it to be used in a variety of functional food and beverage applications, in addition to supplements. For more information on Cognizin visit

About Kyowa Hakko USA

Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin(R) Citicoline, Hydrafend(TM) Hyaluronic Acid, Lumistor(R) L-Hydroxyproline, Setria(R) Glutathione, Kyowa CoQ10(TM) as well as Sustamine(TM) L-Alanyl-L-Glutamine.